Investigating the impact of neoadjuvant chemotherapy on physical functions in breast cancer patients
Investigation of the Effect of Neoadjuvant Chemotherapy on Physical Functions in Women With Breast Cancer
This study is testing how neoadjuvant chemotherapy affects the physical abilities of people with breast cancer by checking their strength, balance, and fatigue before and after treatment.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 46 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | Female |
| Sponsor | Pamukkale University Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Denizli) |
| Trial ID | NCT06986005 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess how neoadjuvant chemotherapy affects the physical functioning of individuals diagnosed with breast cancer. Participants will undergo a series of physical evaluations before and after their chemotherapy treatment, including tests for muscle strength, balance, and fatigue levels. The study will collect demographic data and analyze the results using various statistical methods to determine the impact of chemotherapy on physical capabilities. A minimum of 46 participants will be included to ensure robust findings.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals who are scheduled to receive neoadjuvant chemotherapy for breast cancer.
Not a fit: Patients with a previous history of breast cancer or other cancers may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide insights into how neoadjuvant chemotherapy influences physical functions, potentially guiding supportive care for breast cancer patients.
How similar studies have performed: While similar studies have explored the effects of chemotherapy on physical functioning, this specific observational approach focusing on neoadjuvant chemotherapy in breast cancer patients is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Individuals who are planned to receive neoadjuvant chemotherapy for breast cancer * Acceptance to participate in the study Exclusion Criteria: * Previous history of breast cancer * History of any other cancer * Refusal to participate in the study * Refusal to continue working
Where this trial is running
Denizli
- Pamukkale University — Denizli, Turkey (Recruiting)
Study contacts
- Study coordinator: Atiye KAŞ ÖZDEMİR, Lecturer PhD
- Email: akas@pau.edu.tr
- Phone: +902584151515
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.